Megan Settle

2.0k citations
11 papers · 1.7k indexed · 2 hit papers · h-index 11

Megan Settle

11 papers receiving 1.7k citations

Hit Papers

Apolipoprotein A-I is a selective target for myeloperoxid...5772004202620112018100200300400500

Peers

Megan Settle
Comparison fields: 5 of 92
  • Clinical Biochemistry 255
  • Immunology 604
  • Endocrinology, Diabetes and Metabolism 443
  • Biochemistry 124
  • Surgery 659
Replace Constanze Bergt with:
Constanze Bergt United States
Masakazu Sakai Japan
Manjula Chaddha United States
Baohai Shao United States
David W. Garber United States
A.J. Lusis United States
Sònia Benı́tez Spain
Angeliki Chroni Greece
John W. Gaubatz United States
Fumihiko Matsuura Japan
Megan Settle relative to Constanze Bergt United States Constanze Bergt's profile →
Citations per field
00.5×1.5×2.1×
Constanze Bergt · 1×
Citations per year

Countries citing papers authored by Megan Settle

Since Specialization
Citations

This map shows the geographic impact of Megan Settle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan Settle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan Settle more than expected).

Fields of papers citing papers by Megan Settle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan Settle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan Settle. The network helps show where Megan Settle may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Megan Settle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Megan Settle Line = papers co-authored together Megan Settle links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1 201465
2 200616
3 200567
4 200543
5 200540
6
Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular diseasebreakdown →
2004563
7 2004173
8
Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular diseasebreakdown →
2004577
9 2004111
10 200472
11 200020

About Megan Settle

Megan Settle is a scholar working on Clinical Biochemistry, Immunology, Physiology, Oncology and Surgery, having authored 11 papers that have together received 1.7k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (6 papers), Cholesterol and Lipid Metabolism (4 papers), Nitric Oxide and Endothelin Effects (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Advanced Glycation End Products research (2 papers) and Blood properties and coagulation (1 paper). The work is most often cited by research in Clinical Biochemistry (255 citations), Immunology (604 citations), Endocrinology, Diabetes and Metabolism (443 citations), Biochemistry (124 citations) and Surgery (659 citations). Megan Settle has collaborated with scholars based in United States, Chile and India. Frequent co-authors include Jonathan D. Smith, Stanley L. Hazen, Michael Kinter, Lemin Zheng, Paul L. Fox, Marlene Goormastic, Harry Ischiropoulos, Mingjiang Sun, Leonor Thomson and Xiaoming Fu. Their work appears in journals such as Journal of Lipid Research, Journal of Clinical Investigation, Journal of Biological Chemistry, Arteriosclerosis Thrombosis and Vascular Biology and Mammalian Genome.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026